Drucken

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

GENEVA, Switzerland --(BUSINESS WIRE)-- 06.02.2025 --

The Wyss Center for Bio and Neuro Engineering is pleased to announce a strategic partnership with BrainScape Medical, a newly established company specializing in long-term brain monitoring and neurostimulation. This collaboration marks a major step in translating innovative neurotechnology into real-world clinical solutions.

The Wyss Center has granted BrainScape Medical an exclusive license for Epios®, a cutting-edge platform designed for continuous, long-term brain activity monitoring. Epios® offers a minimally invasive solution for diagnosing and treating neurological disorders, with first-in-human trials demonstrating promising results.

Transforming Neurological Care with Epios®
Epios® provides full-head subscalp EEG monitoring using minimally invasive electrodes, allowing for continuous brain activity recording. This is critical for managing conditions such as epilepsy and dementia. Uniquely, the system integrates both monitoring and neuromodulation, enabling real-time therapeutic interventions.
Dr. Erwin Böttinger, Director of the Wyss Center, stated, "We are thrilled to see Epios® progressing toward clinical application. Our partnership with BrainScape Medical reflects our commitment to advancing impactful neurotechnologies that have market impact and directly benefit patients."

Laura Johnson, CEO of BrainScape Medical, added, "Epios® represents a significant advancement in neurotechnology. Our goal is to bring this innovative solution to patients worldwide, improving their experience managing and living with their neurological disorder through better diagnosis and treatment."

About Wyss Center: The Wyss Center is an independent, not-for-profit organization focused on advancing neurotechnologies to improve the lives of people with neurological and mental health disorders. Based at Campus Biotech in Geneva, Switzerland, the Center develops transformative solutions in artificial intelligence, bioengineering, and neuroengineering to restore essential neural functions and deliver precision therapies. Established in 2014 with the support of Swiss entrepreneur and philanthropist Hansjörg Wyss, the Center collaborates with academic, clinical, and industry partners globally to drive innovation and maximize clinical impact.

NOTE: Epios is a registered Trademark.

Wyss Center for Bio and Neuro Engineering
Aldonza Gübeli
Email: aldonza.gubeli@wysscenter.ch
Website: www.wysscenter.ch

BrainScape Medical
Laura Johnson, CEO
Email: laura.johnson@brainscape-medical.com
Website: www.brainscape-medical.com

Business Wire

Zeit Meldung
07:44 BUSINESS WIRE: Brisbane Airport entscheidet sich f
06:23 BUSINESS WIRE: Gesundheit von Astronauten während
02:53 BUSINESS WIRE: Cloudflare bringt die erste Cloud-n
02:44 BUSINESS WIRE: H2SITE und SNAM kooperieren bei inn
17.03. BUSINESS WIRE: Incyte gibt positive Topline-Ergebn
17.03. BUSINESS WIRE: Futur veröffentlicht Jahres- und Na
17.03. BUSINESS WIRE: Egle Therapeutics Receives €9.3 Mil
17.03. BUSINESS WIRE: Die Welt feiert Irland an diesem St
17.03. BUSINESS WIRE: Business Wire Launches New Business
17.03. BUSINESS WIRE: Die Risiken der Expansion in IT-Kan
17.03. BUSINESS WIRE: Cineca wird über Italiens leistungs
17.03. BUSINESS WIRE: Persönliche Entwicklung durch Marke
17.03. BUSINESS WIRE: PUMA WIRD OFFIZIELLER PARTNER DER P
17.03. BUSINESS WIRE: DataGuard gibt strategische Partner
17.03. BUSINESS WIRE: Erklärung von Appaloosa zur Ankündi
17.03. BUSINESS WIRE: Adara Ventures gibt erstes Closing
17.03. BUSINESS WIRE: NTT DATA and CrowdStrike Expand Par
17.03. BUSINESS WIRE: BMW Group eröffnet Plugfest zur Unt
17.03. BUSINESS WIRE: Alipay+ Empowers New Growth Opportu
17.03. BUSINESS WIRE: Bureau Veritas Strengthens Its Lead
14.03. BUSINESS WIRE: SES Update on Annual General Meetin
14.03. BUSINESS WIRE: Xsolla präsentiert innovative Game
14.03. BUSINESS WIRE: bd-capital raises €430 million for
14.03. BUSINESS WIRE: Kinaxis von der Carleton University
14.03. BUSINESS WIRE: Reply auf der NVIDIA GTC 2025: Wie

Mehr Marktdaten und Kurse finden Sie auf www.finanztreff.de

Angebote der
Nutzungshinweise | Datenschutz | Impressum | Datenquellen: boerse-stuttgart.de,